MedTrace Logo

Survey of COVID-19 Infection

NCT05706064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200000

Last updated 2024-01-24

No results posted yet for this study

Summary

Using online questionnaires, we will obtain data regarding COVID-19 infection and treatment, including incidence rate, hospitalization rate, severity of the infection, medications, mortality rate, etc, in both hospital and communities after the change of disease control policy in China.

Conditions

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Ling Tao, MD, Ph.D. · Xijing Hospital

  • Chao Gao, MD, Ph.D. · Xijing Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-28
Primary Completion
2023-04-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05706064 on ClinicalTrials.gov